Argiles G, Margalef NM, Valladares-Ayerbes M, de Prado JV, et al. Results of REARRANGE trial: A randomized phase 2 study comparing different dosing
approaches for regorafenib (REG) during the first cycle of treatment in patients
(pts) with metastatic colorectal cancer (mCRC). Ann Oncol 2019;30 Suppl 4:iv135.
PMID: 32085044